Palliative care in primary care as a function of patient comorbidity
DOI:
https://doi.org/10.35381/s.v.v6i11.1670Keywords:
Nursing care, palliative care, primary health care. (Source, DeCS).Abstract
Objective: To verify in the literature palliative care in primary care according to the patient's comorbidity. Method: systematic review of the scientific literature using the PRISMA procedure. Results: 15 articles related to the subject. Conclusion: Palliative care in primary care by nursing staff should be developed from a holistic conception of the patient in accordance with transferring this vision to the training plans in undergraduate and postgraduate studies, being considerable to involve training in ICT in terms of computerized modeling plans as a cooperation of pursuing a patient care plan in diligence of attending in advance possible complications due to comorbidity.
Downloads
References
Estévez MJM. Cuidados Paliativos y Atención Primaria: integración o nuevo paradigma [Palliative and Primary Care: link or new paradigm]. Semergen. 2019;45(5):285-287. Spanish. doi: 10.1016/j.semerg.2019.07.001. PMID: 31349957.
Justino ET, Kasper M, Santos KDS, Quaglio RC, Fortuna CM. Palliative care in primary health care: scoping review. Rev Lat Am Enfermagem. 2020; 28:e3324. doi: 10.1590/1518-8345.3858.3324. PMID: 32609270; PMCID: PMC7332247.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097. PMID: 19621072; PMCID: PMC2707599.
Leahy LG. Diagnosis and treatment of ADHD in children vs adults: What nurses should know. Arch Psychiatr Nurs. 2018;32(6):890-895. doi:10.1016/j.apnu.2018.06.013
Waldrop D, Irwin C, Nicholson WC, et al. The Intersection of Cognitive Ability and HIV: A Review of the State of the Nursing Science. J Assoc Nurses AIDS Care. 2021;32(3):306-321. doi:10.1097/JNC.0000000000000232
Tobolowsky FA, Bardossy AC, Currie DW, et al. Signs, Symptoms, and Comorbidities Associated With Onset and Prognosis of COVID-19 in a Nursing Home. J Am Med Dir Assoc. 2021;22(3):498-503. doi:10.1016/j.jamda.2021.01.070
White EM, Saade EA, Yang X, et al. SARS-CoV-2 antibody detection in skilled nursing facility residents. J Am Geriatr Soc. 2021;69(7):1722-1728. doi:10.1111/jgs.17061
McAvay GJ, Vander Wyk B, Allore H. Individual Heterogeneity in the Probability of Hospitalization, Skilled Nursing Facility Admission, and Mortality. J Gerontol A Biol Sci Med Sci. 2021;76(9):1668-1677. doi:10.1093/gerona/glaa314
Kurichi JE, Bogner HR, Streim JE, et al. Predicting 3-year mortality and admission to acute-care hospitals, skilled nursing facilities, and long-term care facilities in Medicare beneficiaries. Arch Gerontol Geriatr. 2017;73:248-256. doi:10.1016/j.archger.2017.08.005
Murphy L, Markey K, O' Donnell C, Moloney M, Doody O. The impact of the COVID-19 pandemic and its related restrictions on people with pre-existent mental health conditions: A scoping review. Arch Psychiatr Nurs. 2021;35(4):375-394. doi:10.1016/j.apnu.2021.05.00
Pathania AS, Prathipati P, Abdul BA, et al. COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges. Theranostics. 2021;11(2):731-753. Published 2021 Jan 1. doi:10.7150/thno.51471
Guan WJ, Liang WH, He JX, Zhong NS. Cardiovascular comorbidity and its impact on patients with COVID-19. Eur Respir J. 2020;55(6):2001227. Published 2020 Jun 11. doi:10.1183/13993003.01227-2020
Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, et al. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther. 2021;19(3):345-357. doi: 10.1080/14787210.2020.1822737
Gasmi A, Peana M, Pivina L, et al. Interrelations between COVID-19 and other disorders. Clin Immunol. 2021;224:108651. doi:10.1016/j.clim.2020.108651
Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40(5):905-919. doi:10.1007/s10096-020-04138-6
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
